BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31859029)

  • 1. Particle filter de-noising of voxel-specific time-activity-curves in personalized
    Götz TI; Lang EW; Schmidkonz C; Maier A; Kuwert T; Ritt P
    Z Med Phys; 2020 May; 30(2):116-134. PubMed ID: 31859029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-dimensional Monte Carlo-based voxel-wise tumor dosimetry in patients with neuroendocrine tumors who underwent
    Goetz TI; Lang EW; Prante O; Maier A; Cordes M; Kuwert T; Ritt P; Schmidkonz C
    Ann Nucl Med; 2020 Apr; 34(4):244-253. PubMed ID: 32114682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deep transformer-based personalized dosimetry from SPECT/CT images: a hybrid approach for [
    Mansouri Z; Salimi Y; Akhavanallaf A; Shiri I; Teixeira EPA; Hou X; Beauregard JM; Rahmim A; Zaidi H
    Eur J Nucl Med Mol Imaging; 2024 May; 51(6):1516-1529. PubMed ID: 38267686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of methods for adapting [Formula: see text] dose-voxel-kernels to tissue inhomogeneities.
    Götz T; Schmidkonz C; Lang EW; Maier A; Kuwert T; Ritt P
    Phys Med Biol; 2019 Dec; 64(24):245011. PubMed ID: 31766045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of kidney dosimetry performed using simplified time activity curve modelling methods: a
    Zhao W; Esquinas PL; Frezza A; Hou X; Beauregard JM; Celler A
    Phys Med Biol; 2019 Aug; 64(17):175006. PubMed ID: 31287093
    [No Abstract]   [Full Text] [Related]  

  • 6. Individualized dosimetry in patients undergoing therapy with (177)Lu-DOTA-D-Phe (1)-Tyr (3)-octreotate.
    Sandström M; Garske U; Granberg D; Sundin A; Lundqvist H
    Eur J Nucl Med Mol Imaging; 2010 Feb; 37(2):212-25. PubMed ID: 19727718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Pipeline for Automated Voxel Dosimetry: Application in Patients with Multi-SPECT/CT Imaging After
    Dewaraja YK; Mirando DM; Peterson AB; Niedbala J; Millet JD; Mikell JK; Frey KA; Wong KK; Wilderman SJ; Nelson AS
    J Nucl Med; 2022 Nov; 63(11):1665-1672. PubMed ID: 35422445
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Menda Y; Madsen MT; O'Dorisio TM; Sunderland JJ; Watkins GL; Dillon JS; Mott SL; Schultz MK; Zamba GKD; Bushnell DL; O'Dorisio MS
    J Nucl Med; 2018 Nov; 59(11):1692-1698. PubMed ID: 29523629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dosimetry procedure for organs-at-risk in
    Marin G; Vanderlinden B; Karfis I; Guiot T; Wimana Z; Reynaert N; Vandenberghe S; Flamen P
    Phys Med; 2018 Dec; 56():41-49. PubMed ID: 30527088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personalized kidney dosimetry in
    Hou X; Zhao W; Beauregard JM; Celler A
    Phys Med Biol; 2019 Aug; 64(17):175004. PubMed ID: 31456584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of voxel S-value methods for personalized voxel-based dosimetry of
    Kim KM; Lee MS; Suh MS; Selvam HSMS; Tan TH; Cheon GJ; Kang KW; Lee JS
    Med Phys; 2022 Mar; 49(3):1888-1901. PubMed ID: 35014699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 4D SPECT/CT acquisition for 3D dose calculation and dose planning in (177)Lu-peptide receptor radionuclide therapy: applications for clinical routine.
    Kairemo K; Kangasmäki A
    Recent Results Cancer Res; 2013; 194():537-50. PubMed ID: 22918781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Voxel-Based Dosimetry of Iron Oxide Nanoparticle-Conjugated
    Gupta A; Shin JH; Lee MS; Park JY; Kim K; Kim JH; Suh M; Park CR; Kim YJ; Song MG; Jeong JM; Lee DS; Lee YS; Lee JS
    Mol Pharm; 2019 Apr; 16(4):1498-1506. PubMed ID: 30821463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Bad Berka dose protocol: comparative results of dosimetry in peptide receptor radionuclide therapy using (177)Lu-DOTATATE, (177)Lu-DOTANOC, and (177)Lu-DOTATOC.
    Schuchardt C; Kulkarni HR; Prasad V; Zachert C; Müller D; Baum RP
    Recent Results Cancer Res; 2013; 194():519-36. PubMed ID: 22918780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personalized dosimetry of
    Carter LM; Ocampo Ramos JC; Kesner AL
    Biomed Phys Eng Express; 2021 Aug; 7(5):. PubMed ID: 34271565
    [No Abstract]   [Full Text] [Related]  

  • 16. Dosimetry of
    Xu L; Meng Q; Yao X; Yang R; Zhang P; Li R; Wang F
    Appl Radiat Isot; 2022 Jan; 179():109975. PubMed ID: 34741954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety, Pharmacokinetics, and Dosimetry of a Long-Acting Radiolabeled Somatostatin Analog
    Zhang J; Wang H; Jacobson O; Cheng Y; Niu G; Li F; Bai C; Zhu Z; Chen X
    J Nucl Med; 2018 Nov; 59(11):1699-1705. PubMed ID: 29653971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of calculation method on kidney dosimetry in
    Heikkonen J; Mäenpää H; Hippeläinen E; Reijonen V; Tenhunen M
    Acta Oncol; 2016; 55(9-10):1069-1076. PubMed ID: 27219529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of [177Lu]PSMA-617 tumor uptake based on voxel-wise 3D Monte Carlo tumor dosimetry in patients with metastasized castration resistant prostate cancer.
    Götz TI; Lang EW; Prante O; Cordes M; Kuwert T; Ritt P; Ludwig B; Schmidkonz C
    Nuklearmedizin; 2020 Sep; 59(5):365-374. PubMed ID: 32663888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetry of
    Violet J; Jackson P; Ferdinandus J; Sandhu S; Akhurst T; Iravani A; Kong G; Kumar AR; Thang SP; Eu P; Scalzo M; Murphy D; Williams S; Hicks RJ; Hofman MS
    J Nucl Med; 2019 Apr; 60(4):517-523. PubMed ID: 30291192
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.